OpenPV Signal Explorer
FAERS disproportionality dashboard
← All drugs
Drug

Triptorelin

102 flagged reaction(s) · 2,595 total co-reports · max PRR 44.1
Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
Reaction Co-reports (a) PRR ROR Signal
1 Needle Issue 197 44.1 46.8 signal
2 Syringe Issue 90 32.8 33.7 signal
3 Affect Lability 39 25.8 26.0 signal
4 Product Use Complaint 51 21.0 21.3 signal
5 Product Administration Error 58 18.5 18.8 signal
6 Mood Altered 78 18.3 18.7 signal
7 Prostatic Specific Antigen Increased 37 17.0 17.2 signal
8 Vaginal Haemorrhage 94 14.1 14.5 signal
9 Metastases To Bone 31 12.1 12.2 signal
10 Product Physical Issue 37 11.8 11.9 signal
11 Mood Swings 55 11.0 11.2 signal
12 Product Prescribing Issue 33 10.3 10.4 signal
13 Increased Appetite 25 8.5 8.5 signal
14 Erectile Dysfunction 31 7.7 7.7 signal
15 Abortion Spontaneous 48 7.6 7.7 signal
16 Personality Change 11 7.5 7.5 signal
17 Dysmenorrhoea 15 7.3 7.3 signal
18 Disease Progression 133 7.2 7.4 signal
19 Hot Flush 78 6.6 6.7 signal
20 Rhabdomyolysis 43 6.6 6.6 signal
21 Vaginal Discharge 10 6.3 6.4 signal
22 Ascites 29 6.3 6.3 signal
23 Inappropriate Antidiuretic Hormone Secretion 10 6.3 6.3 signal
24 Incorrect Route Of Product Administration 16 6.1 6.1 signal
25 Metastases To Liver 16 5.8 5.8 signal
26 Emotional Disorder 28 5.7 5.8 signal
27 Osteonecrosis Of Jaw 22 5.6 5.6 signal
28 Cytopenia 10 5.3 5.3 signal
29 Crying 29 5.1 5.1 signal
30 Hypocalcaemia 15 5.1 5.1 signal
31 Acne 60 5.0 5.1 signal
32 Osteopenia 12 5.0 5.0 signal
33 Hepatic Cytolysis 9 4.7 4.7 signal
34 Malignant Neoplasm Progression 75 4.7 4.8 signal
35 Cholestasis 14 4.7 4.7 signal
36 Hypercholesterolaemia 7 4.7 4.7 signal
37 Haematuria 24 4.5 4.5 signal
38 Toxic Skin Eruption 7 4.4 4.4 signal
39 Drug Level Decreased 7 4.4 4.4 signal
40 Ventricular Extrasystoles 7 4.3 4.3 signal
41 Hepatic Failure 20 4.2 4.2 signal
42 Breast Pain 7 4.2 4.2 signal
43 Appendicitis 6 4.1 4.1 signal
44 Aggression 32 4.1 4.1 signal
45 Sinus Bradycardia 6 3.9 3.9 signal
46 Metastases To Lung 7 3.9 3.9 signal
47 Pelvic Pain 11 3.8 3.9 signal
48 Ischaemic Stroke 10 3.6 3.6 signal
49 Muscle Atrophy 7 3.5 3.5 signal
50 Brain Neoplasm 5 3.5 3.5 signal
51 Increased Tendency To Bruise 5 3.5 3.5 signal
52 Nephropathy Toxic 6 3.4 3.4 signal
53 Disease Recurrence 25 3.3 3.4 signal
54 Thyroid Disorder 8 3.3 3.3 signal
55 Polyneuropathy 6 3.2 3.2 signal
56 Anger 17 3.2 3.2 signal
57 Ovarian Cyst 5 3.2 3.2 signal
58 Meningioma 7 3.0 3.0 signal
59 Circulatory Collapse 8 3.0 3.0 signal
60 Device Mechanical Issue 6 3.0 3.0 signal
61 Irritability 28 3.0 3.0 signal
62 Metrorrhagia 8 2.9 2.9 signal
63 Weight Increased 102 2.9 3.0 signal
64 Abnormal Behaviour 18 2.9 2.9 signal
65 Hepatotoxicity 10 2.9 2.9 signal
66 Intentional Self-injury 9 2.8 2.8 signal
67 Product Administered At Inappropriate Site 8 2.8 2.8 signal
68 Product Dose Omission Issue 122 2.7 2.8 signal
69 Bone Pain 25 2.7 2.7 signal
70 Pericarditis 7 2.7 2.7 signal
71 Hyperthyroidism 6 2.6 2.6 signal
72 Therapeutic Response Shortened 13 2.6 2.6 signal
73 Libido Decreased 5 2.6 2.6 no signal
74 Poor Quality Product Administered 4 2.5 2.5 no signal
75 Neutropenia 52 2.4 2.5 signal
76 Hunger 5 2.4 2.4 no signal
77 Gynaecomastia 11 2.2 2.2 signal
78 Incorrect Dose Administered 78 2.2 2.2 signal
79 Therapeutic Product Effect Decreased 15 2.1 2.2 signal
80 Injection Site Pain 102 2.1 2.2 signal
81 Prostate Cancer 27 2.1 2.1 signal
82 Wrong Technique In Device Usage Process 15 2.1 2.1 signal
83 Agranulocytosis 6 2.1 2.1 no signal
84 Injection Site Extravasation 4 2.0 2.0 no signal
85 Product Dose Omission 20 1.9 1.9 no signal
86 Central Nervous System Lesion 4 1.8 1.8 no signal
87 Injection Site Nodule 3 1.7 1.7 no signal
88 Menstruation Irregular 7 1.7 1.7 no signal
89 Osteonecrosis 8 1.5 1.5 no signal
90 Hair Colour Changes 3 1.5 1.5 no signal
91 Device Leakage 10 1.5 1.5 no signal
92 Palmar-plantar Erythrodysaesthesia Syndrome 5 1.4 1.4 no signal
93 Product Preparation Error 4 1.2 1.2 no signal
94 Injection Site Mass 6 1.0 1.0 no signal
95 Device Issue 14 1.0 1.0 no signal
96 Injection Site Rash 4 0.8 0.8 no signal
97 Breast Cancer 12 0.8 0.8 no signal
98 Incorrect Dose Administered By Device 3 0.8 0.8 no signal
99 Myelosuppression 4 0.7 0.7 no signal
100 Device Delivery System Issue 3 0.7 0.7 no signal
101 Drug Dose Omission By Device 7 0.6 0.6 no signal
102 Bladder Cancer 3 0.3 0.3 no signal